Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00385502 · ClinicalTrials.gov registry record · Phase 2
A Trial of the Safety and Efficacy of EcoNail™ in the Treatment of Fungus Infections of the Great Toenail
A Phase 2 study, sponsored by Abeona Therapeutics.
- Completed
- Registry status
- Phase 2
- Development phase
- 40
- Enrollment target
NCT00385502 is a Phase 2 study that has completed, run by Abeona Therapeutics. The registered enrollment target is 40 participants.
The verdict
NCT00385502, a Phase 2 study, has completed, sponsored by Abeona Therapeutics.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 40 participants
- Enrollment target
Study Summary
Approximately 40 qualified subjects with mild-to-moderate great toenail fungus infection will be treated for 48 weeks with lacquer application to at least one affected great toenail. All subjects will receive treatment with EcoNail™ lacquer.
Interventions
- DRUG EcoNail™ (econazole 5%/SEPA® 18% nail lacquer)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2006-09 |
| Est. Completion | 2008-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00385502
The ClinicalTrials.gov registry entry for NCT00385502 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abeona Therapeutics, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which EcoNail™ (econazole 5%/SEPA® 18% nail lacquer) is the first listed.
NCT00385502 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00385502 about?
NCT00385502 is a clinical study titled "A Trial of the Safety and Efficacy of EcoNail™ in the Treatment of Fungus Infections of the Great Toenail". Approximately 40 qualified subjects with mild-to-moderate great toenail fungus infection will be treated for 48 weeks with lacquer application to at least one affected great toenail. All subjects will receive treatment with EcoNail™ lacquer.
What is the current status of trial NCT00385502?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 40 participants. The study started on 2006-09. Estimated completion is 2008-06.
What interventions are being tested in trial NCT00385502?
The interventions under investigation include: EcoNail™ (econazole 5%/SEPA® 18% nail lacquer) (DRUG).
Who is sponsoring clinical trial NCT00385502?
This trial is sponsored by Abeona Therapeutics, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.